test

Kevin Tang

@Tang Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$1.4BTotal holdings154
Assets growth rate42.57%Assets growth rate (2-Q avg)22.41%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Tang Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 154 positions.

Assets under management

The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.4B in assets, with a quarterly growth rate of 42.57% and a 2-quarter average growth rate of 22.41%. The portfolio is managed by Kevin Tang, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AVIRAtea Pharmaceuticals Inc
Recent Activity
Increased 2.92%
1.11%
$15.434M
4.607M shares@ $3.35 avg price
METAMeta Platforms Inc
Recent Activity
Increased 126.88%
1.06%
$14.801M
25,855 shares@ $572.46 avg price
REPLReplimune Group Inc
Recent Activity
Increased 48.99%
0.94%
$13.152M
1.2M shares@ $10.96 avg price
RVNCRevance Therapeutics Inc
Recent Activity
Increased 525%
0.93%
$12.975M
2.5M shares@ $5.19 avg price
CRGXCargo Therapeutics Inc
Recent Activity
Increased 22.36%
0.93%
$12.929M
700,749 shares@ $18.45 avg price
TDOCTeladoc Health Inc
Recent Activity
Increased 40%
0.92%
$12.852M
1.4M shares@ $9.18 avg price
VNDAVanda Pharmaceuticals Inc
Recent Activity
Increased 9.29%
0.79%
$11.037M
2.353M shares@ $4.7 avg price
CTMXCytomx Therapeutics Inc
Recent Activity
Increased 0.26%
0.66%
$9.218M
7.812M shares@ $1.19 avg price
NUVBNuvation Bio Inc
Recent Activity
Increased 3.95%
0.64%
$8.931M
3.9M shares@ $2.29 avg price
LQDALiquidia Corporation
Recent Activity
Increased 128.58%
0.58%
$8M
800,000 shares@ $10.0 avg price